December 1, 2022
LIVTENCITY™ (maribavir) Receives Positive CADTH Recommendation for Adults with Post-Transplant Cytomegalovirus (CMV) Infection
November 21, 2022
Takeda Receives Prestigious Prix Galien Canada Innovative Product Award for TAKHZYRO® (lanadelumab)
No current content.